Skip to main content
. 2014 Aug 13;8:39–43. doi: 10.4137/DTI.S16524

Figure 1.

Figure 1

The serum UA levels before and after the initiation of the treatment with oral febuxostat. After six months of febuxostat treatment, the serum UA levels were significantly decreased from those at baseline. All patients were entered into the six-month treatment period from July through August 2012. Note that the decrease in the serum UA levels was already significant after one month treatment with febuxostat.

Notes: N = 17, **P < 0.01 versus baseline.